Alyeska Investment Group, L.P. ELUT AZIYO BIOLOGICS INC

Ownership history in Alyeska Investment Group, L.P.  ·  14 quarters on record

AI Ownership Summary

Alyeska Investment Group, L.P. reported AZIYO BIOLOGICS INC (ELUT) in 14 quarterly 13F filings from 2023 Q4 through 2025 Q4. Peak portfolio weight reached 0.03% in 2025 Q1. The latest visible filing shows ELUT at 0.00% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this ELUT ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Alyeska Investment Group, L.P.'s position in AZIYO BIOLOGICS INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2025 Q4

ELUT was reported at 0.00% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.03% in 2025 Q1

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2023 Q4 to 2025 Q4

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

How Alyeska Investment Group, L.P. held ELUT — position size vs. price
% of Fund (quarterly)    ELUT price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 10 quarters  
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2025 Q4 REDUCED 51.5% +52.2% 1,281,172 -1,362,273 -51.5% 0.00% $887K 2026-02-13 $1.05
2025 Q3 UNCHANGED 2,643,445 0% 0.01% $2.4M 2025-11-17 $0.73
2025 Q2 UNCHANGED 2,643,445 0% 0.02% $5.2M 2025-08-14 $2.15
2025 Q1 ADDED 2,643,445 +2,000,000 +310.8% 0.03% $6.7M 2025-05-15 $1.74
2024 Q4 UNCHANGED 643,445 0% 0.01% $2.4M 2025-02-14 $2.82
2024 Q3 REDUCED 28.0% +2.1% 643,445 -250,000 -28.0% 0.01% $2.5M 2024-11-14 $3.83
2024 Q2 ADDED 893,445 +801,468 +871.4% 0.03% $4.4M 2024-08-14 $3.30
2024 Q2 REDUCED 89.7% -23.2% 91,977 -801,468 -89.7% 0.00% $456K 2024-08-14 $3.30
2024 Q1 UNCHANGED 893,445 0% 0.02% $2.8M 2024-05-15 $3.28
2023 Q4 ADDED 893,445 +230,201 +34.7% 0.01% $1.9M 2024-02-14 $3.95
4 older quarters hidden  —  Sign in free or upgrade to Premium to see full history

FAQ About Alyeska Investment Group, L.P. and ELUT

These are the practical questions this page is built to answer before you even open the full history table.

How long has Alyeska Investment Group, L.P. reported owning ELUT?

Alyeska Investment Group, L.P. reported ELUT across 10 quarterly 13F filings, from 2023 Q4 through 2025 Q4.

What was the largest reported ELUT position in Alyeska Investment Group, L.P.'s portfolio?

The largest reported portfolio weight for ELUT was 0.03% in 2025 Q1.

What is the latest reported ELUT position on this page?

The most recent filing on this page is 2025 Q4, when Alyeska Investment Group, L.P. reported 1,281,172 shares, equal to 0.00% of portfolio, with an estimated market value of $887K.

What does the chart on this ELUT ownership page compare?

The chart compares Alyeska Investment Group, L.P.'s quarterly ELUT portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did Alyeska Investment Group, L.P. time their ELUT position?

Based on 13F filing dates vs. subsequent ELUT price moves, Alyeska Investment Group, L.P. correctly timed 6 out of 8 reported position changes (75%). The annualised alpha on ELUT relative to SPY over the holding period was -47.3%.

← Back to Alyeska Investment Group, L.P. Holdings